Nonparametric Assessment of Differences Between Competing Risk Hazard Ratios: Application to Racial Differences in Pediatric Chronic Kidney Disease Progression

References

• Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541–554. doi:10.2307/2530374373811
   PubMed Web of Science ®Google Scholar
• Crowder MJ. Classical Competing Risks. Boca Raton, FL: CRC Press; 2001.
   Google Scholar
• Pintilie M. Competing Risks: A Practical Perspective. Chichester, England: John Wiley & Sons; 2006.
   Google Scholar
• Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389–2430. doi:10.1002/sim.271217031868
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170:244–256. doi:10.1093/aje/kwp10719494242
   PubMed Web of Science ®Google Scholar
• Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41:861–870. doi:10.1093/ije/dyr21322253319
   PubMed Web of Science ®Google Scholar
• Kuk D, Varadhan R. Model selection in competing risks regression. Stat Med. 2013;32:3077–3088. doi:10.1002/sim.576223436643
   PubMed Web of Science ®Google Scholar
• Taghipour S, Banjevic D, Miller A, Harvey B. Competing risks models and breast cancer: a brief review In: M-LT L, Gail M, Pfeiffer R, Satten G, Cai T, Gandy A, editors. Risk Assessment and Evaluation of Predictions. New York: Springer; 2013:301–313.
   Google Scholar
• Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133:601–609. doi:10.1161/CIRCULATIONAHA.115.01771926858290
   PubMed Web of Science ®Google Scholar
• Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400–409. doi:10.2307/2290318
   Web of Science ®Google Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496. doi:10.2307/2670170
   Web of Science ®Google Scholar
• Andersen PK, Keiding N. Interpretability and importance of functionals in competing risks and multistate models. Stat Med. 2012;31:1074–1088. doi:10.1002/sim.438522081496
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Stat Med. 2011;30:654–665. doi:10.1002/sim.412321337360
   PubMed Web of Science ®Google Scholar
• Ren X, Li S, Shen C, Yu Z. Linear and nonlinear variable selection in competing risks data. Stat Med. 2018;37:2134–2147. doi:10.1002/sim.763729579776
   PubMed Web of Science ®Google Scholar
• Troendle JF, Leifer ES, Kunz L. Dealing with competing risks in clinical trials: how to choose the primary efficacy analysis? Stat Med. 2018;37:2787–2796. doi:10.1002/sim.7800
   Web of Science ®Google Scholar
• Wolbers M, Koller MT, Witteman JCM, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009;20:555–561. doi:10.1097/EDE.0b013e3181a3905619367167
   PubMed Web of Science ®Google Scholar
• Koller MT, Raatz H, Steyerberg EW, Wolbers M. Competing risks and the clinical community: irrelevance or ignorance? Stat Med. 2012;31:1089–1097. doi:10.1002/sim.438421953401
   PubMed Web of Science ®Google Scholar
• Wolbers M, Koller MT, Stel VS, et al. Competing risks analyses: objectives and approaches. Eur Heart J. 2014;35:2936–2941. doi:10.1093/eurheartj/ehu13124711436
   PubMed Web of Science ®Google Scholar
• Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol. 2013;66:648–653. doi:10.1016/j.jclinepi.2012.09.01723415868
   PubMed Web of Science ®Google Scholar
• Poythress JC, Lee MY, Young J. Planning and analyzing clinical trials with competing risks: recommendations for choosing appropriate statistical methodology. Pharm Stat. 2019. doi:10.1002/pst.1966
   Web of Science ®Google Scholar
• Wolkewitz M, Palomar-Martinez M, Olaechea-Astigarraga P, Alvarez-Lerma F, Schumacher M. A full competing risk analysis of hospital-acquired infections can easily be performed by a case-cohort approach. J Clin Epidemiol. 2016;74:187–193. doi:10.1016/j.jclinepi.2015.11.01126633600
   PubMed Web of Science ®Google Scholar
• Hsu JY, Roy JA, Xie D, et al. Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks. Clin J Am Soc Nephrol 2017;12:1181–1189. doi:10.2215/CJN.10301016.
   Google Scholar
• Beyersmann J, Latouche A, Buchholz A, Schumacher M. Simulating competing risks data in survival analysis. Stat Med. 2009;28:956–971. doi:10.1002/sim.351619125387
   PubMed Web of Science ®Google Scholar
• Muñoz A, Abraham AG, Matheson M, Wada N. Non-proportionality of hazards in the competing risks framework In: M-LT L, Gail M, Pfeiffer R, Satten G, Cai T, Gandy A, editors. Risk Assessment and Evaluation of Predictions. New York: Springer; 2013:3–22.
   Google Scholar
• Checkley W, Brower RG, Muñoz A. Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology. 2010;21:557–565. doi:10.1097/EDE.0b013e3181e090ed.20502337
   PubMed Web of Science ®Google Scholar
• Scrutinio D, Guida P, Passantino A, et al. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction. J Clin Epidemiol. 2018;103:31–39. doi:10.1016/j.jclinepi.2018.07.00630009940
   PubMed Web of Science ®Google Scholar
• Austin PC, Fine JP. Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement. Stat Med. 2017;36:1203–1209. doi:10.1002/sim.721528102550
   PubMed Web of Science ®Google Scholar
• Ng DK, Moxey-Mims M, Warady BA, Furth SL, Muñoz A. Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease. Ann Epidemiol. 2016;26:780–787.e1. doi:10.1016/j.annepidem.2016.09.01127789133
   PubMed Web of Science ®Google Scholar
• Pepe MS, Mori M. Kaplan–Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 1993;12:737–751. doi:10.1002/(ISSN)1097-02588516591
   PubMed Web of Science ®Google Scholar
• Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006;1:1006–1015. doi:10.2215/CJN.0194120517699320
   PubMed Web of Science ®Google Scholar
• Wong CS, Pierce CB, Cole SR, et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009;4:812–819. doi:10.2215/CJN.0178040819297612
   PubMed Web of Science ®Google Scholar
• Pierce CB, Cox C, Saland JM, Furth SL, Muñoz A. Methods for characterizing differences in longitudinal glomerular filtration rate changes between children with glomerular chronic kidney disease and those with nonglomerular chronic kidney disease. Am J Epidemiol. 2011;174:604–612. doi:10.1093/aje/kwr12121828368
   PubMed Web of Science ®Google Scholar
• Babiker A, Darbyshire J, Pezzotti P, et al. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol. 2002;31:951–958.12435766
   PubMed Web of Science ®Google Scholar
• Lim HJ, Zhang X, Dyck R, Osgood N. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes. BMC Med Res Methodol. 2010;10:97. doi:10.1186/1471-2288-10-9720964855
   PubMed Web of Science ®Google Scholar
• Noordzij M, Leffondré K, van Stralen KJ, Zoccali C, Dekker FW, Jager KJ. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant. 2013;28:2670–2677. doi:10.1093/ndt/gft35523975843
   PubMed Web of Science ®Google Scholar
• Latouche A, Boisson V, Chevret S, Porcher R. Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med. 2007;26:965–974. doi:10.1002/sim.260016755533
   PubMed Web of Science ®Google Scholar